Ezgi Ozturk

Ezgi Ozturk is a female medical professional who specializes in treating various conditions such as epilepsy, juvenile absence epilepsy, post-traumatic epilepsy, absence seizures, CACH syndrome, generalized tonic-clonic seizures, hypothalamic hamartomas, lissencephaly, Miller-Dieker syndrome, mosaicism, multiple sclerosis (MS), seizures, Sturge-Weber syndrome, subcortical band heterotopia, and traumatic brain injury.

Ezgi Ozturk helps patients with these conditions by providing expert care and using special skills and treatments to improve their health. She communicates effectively with patients, explaining medical information clearly and building trust through her compassionate approach to care.

To stay updated with the latest medical knowledge and research, Ezgi Ozturk regularly attends conferences, reads scientific journals, and collaborates with other healthcare professionals. By staying informed about advancements in the field, she ensures that her patients receive the best possible care based on current evidence-based practices.

Ezgi Ozturk works closely with her colleagues and values teamwork in providing comprehensive care to patients. She believes in a multidisciplinary approach to healthcare, collaborating with other medical professionals to develop personalized treatment plans for each patient.

Through her dedication and expertise, Ezgi Ozturk has made a positive impact on many patients' lives by improving their health outcomes and quality of life. Her research on epilepsy, such as the study "Fluoxetine accelerates epileptogenesis and magnifies disease severity in a rat model of acquired epilepsy," published in Epilepsia, contributes to advancing medical knowledge and improving treatment options for patients with epilepsy.

In summary, Ezgi Ozturk is a skilled and compassionate medical professional who goes above and beyond to provide exceptional care to her patients and contribute to advancements in the field of epilepsy research.